Aviceda Therapeutics

Start Date End Date Funded Value Relevance

CSV

25 50 100

£531,067

Aug 12 - Aug 15

Development of a novel anti-inflammatory nanoparticle for the treatment of Acute Lung Injury

MRC award to Queen's University Belfast and Christopher Scott

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}